The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

BACKGROUND: Temozolomide is applied as the standard chemotherapy agent in patients with glioblastoma (GBM) after surgery. However, the benefit of this treatment for patients is limited by the invasive growth of gliomas and drug resistance. There are indications from fundamental experimental and retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Maoyuan, Huang, Ning, Tao, Yihao, Wen, Rong, Zhao, Guanjian, Zhang, Xiang, Xie, Zongyi, Cheng, Yuan, Mao, Jinning, Liu, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962067/
https://www.ncbi.nlm.nih.gov/pubmed/35346332
http://dx.doi.org/10.1186/s13063-022-06168-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962067/
https://www.ncbi.nlm.nih.gov/pubmed/35346332
http://dx.doi.org/10.1186/s13063-022-06168-1

Ejemplares similares